Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,237 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05941507RecruitingPhase 1/Phase 2
TROP2 antibody drug with anti–PD-1 for advanced solid tumors
This early-phase study tests an antibody-drug (an ADC) that targets TROP2, given by itself and together with an anti–PD-1 medicine. It’s for people with advanced solid cancers that have not responded to standard treatments, aiming to shrink tumors and improve control of the disease.
Los Angeles, CaliforniaAges 18 years+ - NCT06311331Enrolling by invitation
Total talus replacement for ankle bone damage
This trial tests a new total talus replacement implant for people with severe talus bone problems like avascular necrosis, non-healing fractures, or large bone defects. It aims to see how well the implant works and how patients recover.
Charlotte, North CarolinaAges 22 years+ - NCT06303986Enrolling by invitation
Observation study for newborns with or without NAS
This study is collecting information from two groups of newborns: those with Neonatal Abstinence Syndrome (NAS, caused by drug exposure before birth) and healthy newborns. The goal is to see if an automated system makes it easier to gather data without extra tests or procedures.
Albuquerque, New MexicoAges Up to 4 weeks - NCT06311682RecruitingPhase 3
Testing a new shot plus steroid cream for children with eczema
This study tests an investigational shot (tralokinumab) plus a steroid cream for children with moderate-to-severe eczema that hasn't been controlled by creams alone. It aims to see if the combination is safe and works better than the cream alone.
Birmingham, AlabamaAges 6 months–11 years - NCT06314282Recruiting
Lupus study tracking real-world results with anifrolumab
This study looks at how well anifrolumab works for people with lupus in everyday medical care, not just in a research lab. It may help you if your doctor has decided to prescribe anifrolumab for the first time.
Buenos AiresAges 18 years+ - NCT06312189Enrolling by invitationPhase 3
Long-term safety study of valbenazine for Huntington's chorea in Canada
This study is for people in Canada who have already been taking valbenazine for Huntington's chorea in a previous study (NBI-98854-HD3006). It tests the long-term safety of the medicine and continues for up to 156 weeks.
Vancouver, British ColumbiaAges 18 years+ - NCT06316297RecruitingPhase 1/Phase 2
Testing a new mRNA vaccine for moderate to severe acne
This study tests an experimental mRNA vaccine designed to help the immune system fight acne-causing bacteria. It's for adults with moderate or severe facial acne who are otherwise healthy, and it may offer a new way to treat acne beyond typical creams or pills.
Scottsdale, ArizonaAges 18–45 - NCT06307665RecruitingPhase 3
Asthma study for teens comparing two inhalers
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
Anchorage, AlaskaAges 12–17 - NCT06307652RecruitingPhase 3
Testing a new heart failure and kidney treatment combo
This study tests a new combination of two medicines (balcinrenone and dapagliflozin) for people with heart failure and reduced kidney function. The goal is to see if this combination helps improve heart and kidney health better than current treatments.
Alexander City, AlabamaAges 18–130 - NCT06306014RecruitingPhase 1/Phase 2
Study of a new therapy to prevent C. diff recurrence
This study tests a new live bacteria product (EXL01) given with vancomycin to prevent C. diff from coming back. It is for people who have already had C. diff two or more times and are at high risk of another infection.
AnnecyAges 18 years+ - NCT06312813RecruitingPhase 2
Testing antidepressant creams for rosacea redness
This study tests if creams containing two antidepressants (imipramine and amitriptyline) can reduce skin redness caused by UV light in people with rosacea. It compares how the creams affect redness to see if they could be a new treatment option.
Fairborn, OhioAges 18 years+ - NCT06315179Recruiting
Spatial gene study for inflammatory bowel disease
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
Seattle, WashingtonAges 6–21 - NCT06302296Recruiting
Speeding up braces with your own blood
This study tests whether a special injection made from your own blood (called injectable platelet-rich fibrin) can help move your teeth faster during braces treatment. It involves removing two upper premolars and then receiving the injection to see if it speeds up straightening.
HamaAges 18–26 - NCT06296368Recruiting
A tool to help older adults make cancer care decisions
This trial tests if a special tool can help adults aged 60 and older who are newly visiting a blood cancer or bone marrow transplant clinic understand their options and make decisions that fit their needs.
Chapel Hill, North CarolinaAges 60 years+ - NCT06295783Recruiting
Study of questionnaires for radiation side effects in head and neck cancer
This study looks at how different questionnaires can better measure the side effects of radiation treatment for head and neck cancer. If you are a current or recent patient, your answers could help improve how doctors monitor and manage these side effects.
Houston, TexasAges 18 years+ - NCT06296472Recruiting
Comparing hand therapy for De Quervain's disease after steroid injection
This trial compares two types of hand therapy for patients with De Quervain's disease, a painful condition affecting the thumb tendons. One group receives standard hand therapy, while the other gets a new approach after an ultrasound-guided steroid injection.
BolognaAges 18 years+ - NCT06298877Recruiting
Stoma reversal and quality of life in ovarian cancer
This study looks at how temporary stoma (a surgical opening in the belly) affects quality of life and recovery in women having surgery for ovarian cancer. It may help doctors decide when to reverse the stoma so you heal better.
Stockholm, SolnaAges 18 years+ - NCT06306326Recruiting
Using 3D scanning to check fat grafting for facial defects
This study uses 3D face scanning to see how well your own fat, taken from another part of your body, can restore fullness to your face. It might help if you have a sunken or uneven look from a birth defect, injury, or aging.
Beijing, Beijing MunicipalityAges 3–80 - NCT06312631Recruiting
Home glove helps stroke survivors use their arm
This study tests a home-use glove (SaeboGlove®) that may help people who had a stroke grip and hold objects with their hand. It looks at how using the glove affects arm function and what factors help people stick with the program.
ToulouseAges 18–90 - NCT05203328Recruiting
Testing high-flow oxygen during EBUS with monitored sedation
This study looks at whether using high-flow oxygen through the nose during a specific lung procedure (EBUS bronchoscopy) is safe and works well while you receive monitored sedation. If you qualify, it may help improve how breathing is supported during the procedure.
Camden, New JerseyAges 18 years+ - NCT05808634RecruitingPhase 1
Testing an investigational drug for advanced lung or gut cancer
This Phase 1 trial tests BA3182, an investigational medicine, in people with advanced adenocarcinoma that cannot be removed by surgery. The goal is to see how the treatment works and whether it’s tolerated, and it may offer an option when standard options have been limited.
Irvine, CaliforniaAges 18 years+ - NCT06242912Recruiting
Cancer treatment study: finding what works best in real life
This British Columbia study looks at how well different cancer treatments work in real life when doctors aren't sure which option is best. You and your doctor would choose a treatment, and researchers will track your results to help others.
Vancouver, British ColumbiaAges 18 years+ - NCT06284317RecruitingPhase 3
Durvalumab after chemo and surgery for early lung cancer
This trial tests adding durvalumab (an immunotherapy) after chemotherapy, surgery, and more durvalumab for people with early-stage, operable non-small cell lung cancer. It aims to see if this extra treatment helps prevent the cancer from coming back.
Camperdown, New South WalesAges 18 years+ - NCT06283966RecruitingPhase 3
Triple inhaler for COPD with heart risk
This study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) to see if it can help protect the heart and lungs in people with COPD who also have heart problems or high risk for them.
Athens, AlabamaAges 40–80
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,237 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.